Prevention of leukocyte migration to inflamed skin with a novel fluorosugar modifier of cutaneous lymphocyte-associated antigen.
about
Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cellsTargeting selectins and selectin ligands in inflammation and cancerLeveraging fluorinated glucosamine action to boost antitumor immunitySkin-homing receptors on effector leukocytes are differentially sensitive to glyco-metabolic antagonism in allergic contact dermatitis.Fluorinated per-acetylated GalNAc metabolically alters glycan structures on leukocyte PSGL-1 and reduces cell binding to selectins.Expression of cutaneous lymphocyte-associated antigen and E-selectin ligand by circulating human memory CD4+ T lymphocytes specific for herpes simplex virus type 2.ST3Gal-4 is the primary sialyltransferase regulating the synthesis of E-, P-, and L-selectin ligands on human myeloid leukocytes.Peracetylated 4-fluoro-glucosamine reduces the content and repertoire of N- and O-glycans without direct incorporation.New insights into atopic dermatitis.A common sugar-nucleotide-mediated mechanism of inhibition of (glycosamino)glycan biosynthesis, as evidenced by 6F-GalNAc (Ac3)Therapeutic potential of selectin antagonists in psoriasis.Synthesis of N-acetyl Glucosamine Analogs as Inhibitors for Hyaluronan Biosynthesis.Vitamins A and D are potent inhibitors of cutaneous lymphocyte-associated antigen expression.Glycan antagonists and inhibitors: a fount for drug discovery.Prophylaxis of acute GVHD: manipulate the graft or the environment?Regulation of heparan sulfate and chondroitin sulfate glycosaminoglycan biosynthesis by 4-fluoro-glucosamine in murine airway smooth muscle cellsAnalysis of physiologic E-selectin-mediated leukocyte rolling on microvascular endothelium.Understanding glycomechanics using mathematical modeling: a review of current approaches to simulate cellular glycosylation reaction networks.Developing inhibitors of glycan processing enzymes as tools for enabling glycobiology.Targeting selectins for the treatment of inflammatory diseases.Selectin and selectin ligand binding: a bittersweet attractionSynthesis and in vitro cytotoxicity of acetylated 3-fluoro, 4-fluoro and 3,4-difluoro analogs of D-glucosamine and D-galactosamineMetabolic inhibition of galectin-1-binding carbohydrates accentuates antitumor immunity.Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome.Interleukin-4 induced down-regulation of skin homing receptor expression by human viral-specific CD8 T cells may contribute to atopic risk of cutaneous infection.Inhibition of fucosylation in human invasive ductal carcinoma reduces E-selectin ligand expression, cell proliferation and ERK1/2 and p38 MAPK activation.E-Selectin Ligands in the Human Mononuclear Phagocyte System: Implications for Infection, Inflammation, and Immunotherapy.
P2860
Q24546102-5EF56951-58F2-4ABF-B8DA-48625F8C4A2AQ24658204-D253537E-8B22-43F8-8180-B49A80C44EF0Q27008230-7594A861-2AD5-4709-92F7-B750190C8BFCQ33606887-0EA22532-0411-4004-9E15-2E01068F53CDQ33677498-3B9B676E-CBD8-4258-B4F0-EF2CFB295B56Q34081662-CDF32EE1-F910-4117-A1B7-8C12759B9FD5Q35004977-875390B0-8B8D-4BA1-8C5A-603C4687F0F2Q35065252-A19121CE-AEA5-4913-9568-41AF439C2471Q35678332-DB6C9B43-AB3A-4D34-8628-6144CE513694Q35774804-DE09CE14-B5D2-4BB0-BD09-EDD1812CC2FCQ36543080-5B845113-AAF9-46E6-9397-1D2DE3E8CCD1Q36807807-EB5B20E4-DDC8-4EF1-9B84-2BBA479C668EQ36934030-1F066A4A-0ADB-45CA-8DE1-6B30B18EA7C6Q37027396-2768E1E7-DD7D-49CC-8ECA-EEFFACAB0BF1Q37173456-4CA5A0AE-0F5E-4D74-81F3-C8BF56DD90B8Q37285056-A57FE479-A9C9-4935-8F24-A92839A200A9Q37315488-3672C4AA-1F59-412F-9DF4-E142198F52B2Q37957027-D35F93FF-2C2B-4DA8-BB35-F46826419F09Q38027408-A0E7016E-4852-48E7-8F56-FDC85F010AADQ38145413-D2F797E7-A9BF-4003-B981-2C28C63999C6Q38349702-0B887D50-5FB0-4690-B1FB-45B449599C8BQ38762512-0F4AAFE9-8CB7-4130-815D-B27987C90B00Q40401752-37D50041-B051-4390-9F55-21BE1E78C626Q42321222-BB5B2824-FFAC-48BD-9307-44B952A204D0Q44364192-D782DA50-DEE9-4D64-B28D-27EC5A7294EEQ47272986-B7F03007-E28E-40D1-BD54-E034484F4879Q50197234-43491893-E62C-4266-9B9B-C0F8F743CFC5
P2860
Prevention of leukocyte migration to inflamed skin with a novel fluorosugar modifier of cutaneous lymphocyte-associated antigen.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Prevention of leukocyte migrat ...... lymphocyte-associated antigen.
@ast
Prevention of leukocyte migrat ...... lymphocyte-associated antigen.
@en
type
label
Prevention of leukocyte migrat ...... lymphocyte-associated antigen.
@ast
Prevention of leukocyte migrat ...... lymphocyte-associated antigen.
@en
prefLabel
Prevention of leukocyte migrat ...... lymphocyte-associated antigen.
@ast
Prevention of leukocyte migrat ...... lymphocyte-associated antigen.
@en
P2093
P2860
P356
P1476
Prevention of leukocyte migrat ...... lymphocyte-associated antigen.
@en
P2093
Charles J Dimitroff
Robert Sackstein
Thomas S Kupper
P2860
P304
P356
10.1172/JCI19220
P407
P577
2003-10-01T00:00:00Z